Xuli Yang

416 total citations
22 papers, 312 citations indexed

About

Xuli Yang is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Xuli Yang has authored 22 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Xuli Yang's work include Pain Mechanisms and Treatments (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Xuli Yang is often cited by papers focused on Pain Mechanisms and Treatments (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Xuli Yang collaborates with scholars based in China and United States. Xuli Yang's co-authors include Yue Sun, Dengfu Yao, Min Yao, Li Wang, Wei Zhang, Yulin Huang, Jing Hao, Xiaoping Gu, Jixiang Zhu and Qian Gao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Free Radical Biology and Medicine and Anesthesia & Analgesia.

In The Last Decade

Xuli Yang

21 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuli Yang China 10 129 71 45 42 42 22 312
Jane L. Cross Australia 11 280 2.2× 42 0.6× 11 0.2× 60 1.4× 23 0.5× 19 439
Jong-Choon Kim South Korea 12 81 0.6× 27 0.4× 16 0.4× 38 0.9× 73 1.7× 13 457
Yaqian Zhao China 9 118 0.9× 39 0.5× 8 0.2× 113 2.7× 14 0.3× 21 381
Zhigang Dai China 12 100 0.8× 31 0.4× 35 0.8× 43 1.0× 81 1.9× 24 320
Yongkang Qiu China 9 65 0.5× 24 0.3× 31 0.7× 24 0.6× 40 1.0× 50 259
Ramkumar Thiyagarajan United States 15 115 0.9× 97 1.4× 5 0.1× 24 0.6× 5 0.1× 26 391
Sufang Jiang China 10 142 1.1× 11 0.2× 22 0.5× 28 0.7× 64 1.5× 24 341
Andrew M. Slupe United States 8 237 1.8× 42 0.6× 25 0.6× 23 0.5× 54 1.3× 9 491

Countries citing papers authored by Xuli Yang

Since Specialization
Citations

This map shows the geographic impact of Xuli Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuli Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuli Yang more than expected).

Fields of papers citing papers by Xuli Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuli Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuli Yang. The network helps show where Xuli Yang may publish in the future.

Co-authorship network of co-authors of Xuli Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuli Yang. A scholar is included among the top collaborators of Xuli Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuli Yang. Xuli Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Wěi, et al.. (2024). Protective effects of ginsenosides on ulcerative colitis: a meta-analysis and systematic review to reveal the mechanisms of action. Inflammopharmacology. 32(5). 3079–3098. 2 indexed citations
3.
Yuan, Ning, John I. Nürnberger, Ney Alliey‐Rodriguez, et al.. (2023). A pilot pharmacogenetic study of calcium channel blocker treatment of bipolar mania. Psychiatry Research. 326. 115281–115281. 4 indexed citations
4.
Wang, Yu, Chenchen Wang, Xuli Yang, et al.. (2023). Inhibition of Cyclophilin A-Metalloproteinase-9 Pathway Alleviates the Development of Neuropathic Pain by Promoting Repair of the Blood-Spinal Cord Barrier. Anesthesia & Analgesia. 138(6). 1313–1323. 3 indexed citations
5.
Yang, Xuli, Tao Chen, Jie Hu, Jian Wang, & Dong Yang. (2022). HKI-272 contributes to gemcitabine-mediated anti-proliferative and anti-metastatic effects through EGFR suppression in gallbladder cancer. Molecular Therapy — Oncolytics. 27. 126–140. 2 indexed citations
7.
Hao, Jing, Xuli Yang, Jixiang Zhu, et al.. (2022). Basolateral Amygdala Reactive Microglia May Contribute to Synaptic Impairment and Depressive-Like Behavior in Mice with Bone Cancer Pain. Neurochemical Research. 47(11). 3454–3463. 8 indexed citations
8.
Yang, Yan, Yue Liu, Jixiang Zhu, et al.. (2021). Neuroinflammation-mediated mitochondrial dysregulation involved in postoperative cognitive dysfunction. Free Radical Biology and Medicine. 178. 134–146. 83 indexed citations
9.
Yang, Xuli, et al.. (2020). Syntenin overexpression in human lung cancer tissue and serum is associated with poor prognosis. BMC Cancer. 20(1). 159–159. 8 indexed citations
10.
Yu, Xiang, et al.. (2019). The crystal structure of (1E,2E)-2-methyl-4-((7-oxo-7H-furo[3,2-g]chromen-9-yl)oxy)but-2-enal O-isonicotinoyl oxime–trichloromethane (3/1), C67H49Cl3N6O18. SHILAP Revista de lepidopterología. 234(5). 1073–1075. 1 indexed citations
11.
Dong, Zhizhen, Xuli Yang, Wenjie Zheng, et al.. (2018). Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition. Oncotarget. 9(16). 12705–12717. 28 indexed citations
12.
Yao, Min, et al.. (2016). Nonalcoholic Lipid Accumulation and Hepatocyte Malignant Transformation. Journal of Clinical and Translational Hepatology. 4(2). 123–30. 11 indexed citations
13.
Yang, Xuli, Li Wang, Wenli Sai, et al.. (2016). Clinicopathological features of hypoxia-inducible factor-1α and vascular endothelial growth factor expression in patients with lung cancer ⁎. Oncology and Translational Medicine. 2(6). 261–267. 1 indexed citations
14.
Yao, Min, et al.. (2016). Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma. World Journal of Gastroenterology. 22(14). 3829–3829. 27 indexed citations
15.
Shi, Yun‐Bo, et al.. (2015). Abnormal expression of VEGF and its gene transcription status as diagnostic indicators in patients with non-small cell lung cancer ⁎. Oncology and Translational Medicine. 1(5). 201–207. 1 indexed citations
16.
Yao, Min, Wenjie Zheng, Xuli Yang, et al.. (2015). Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma. Tumor Biology. 37(4). 5561–5568. 16 indexed citations
17.
Yang, Xuli, Yue Liu, Zheng Xu, et al.. (2014). The risk factors for delirium in older orthopedic surgery patients in post-anesthesia care unit after general anesthesia. 35(6). 524–526. 1 indexed citations
18.
Liu, Yue, Ying Liang, Bailing Hou, et al.. (2014). The inhibitor of calcium/calmodulin-dependent protein kinase II KN93 attenuates bone cancer pain via inhibition of KIF17/NR2B trafficking in mice. Pharmacology Biochemistry and Behavior. 124. 19–26. 25 indexed citations
19.
Liu, Yue, Yue Sun, Xuli Yang, et al.. (2014). Intrathecal Injection of the Peptide Myr-NR2B9c Attenuates Bone Cancer Pain Via Perturbing N-Methyl-D-Aspartate Receptor-PSD-95 Protein Interactions in Mice. Anesthesia & Analgesia. 118(6). 1345–1354. 25 indexed citations
20.
Chen, Zhiran, Heng Guo, Hailong Tang, et al.. (2013). Preparation and properties of bisphenol A‐based bis‐phthalonitrile composite laminates. Journal of Applied Polymer Science. 129(5). 2621–2628. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026